Used as a key intermediate in the synthesis of kinase inhibitors for targeted cancer therapies. Its structure enables selective binding to enzyme active sites, making it valuable in developing pharmaceuticals for treating solid tumors and hematological malignancies. Commonly employed in research settings to design compounds with improved potency and selectivity against specific protein kinases involved in disease pathways.